REVELATION BIOSCIENCES, INC. Operating Lease, Liability, Noncurrent
REVELATION BIOSCIENCES, INC. (REVB) had Operating Lease, Liability, Noncurrent of $550.55 thousand as of 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Balance Sheet › Liabilities
us-gaap:OperatingLeaseLiabilityNoncurrent · last filed 2026-08-06
- 2026-06-30: Operating Lease, Liability, Noncurrent $550.55K.
- 2026-03-31: Operating Lease, Liability, Noncurrent $638.18K.
- 2025-12-31: Operating Lease, Liability, Noncurrent $723.77K.
- 2024-12-31: Operating Lease, Liability, Noncurrent $0.00.
| Period end | Operating Lease, Liability, Noncurrent |
|---|---|
| 2026-06-30 | $550.55K 10-Q · filed 2026-08-06 |
| 2026-03-31 | $638.18K 10-Q · filed 2026-05-07 |
| 2025-12-31 | $723.77K 10-Q · filed 2026-08-06 |
| 2024-12-31 | $0.00 10-K · filed 2026-02-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| HCW Biologics Inc. (HCWB) | United States | $0.004B | -6.15 |
| Onconetix, Inc. (ONCO) | United States | $0.004B | |
| Aptevo Therapeutics Inc. (APVO) | United States | $0.003B | |
| 60 DEGREES PHARMACEUTICALS, INC. (SXTP) | United States | $0.004B | -0.59 |
| Sunshine Biopharma Inc. (SBFM) | $0.003B | ||
| Lakewood-Amedex Biotherapeutics Inc. (LABT) | United States | $0.004B | |
| Cadrenal Therapeutics, Inc. (CVKD) | United States | $0.004B | -0.90 |
| Alaunos Therapeutics, Inc. (TCRT) | United States | $0.003B | -1.44 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |